Genomic Variant Impact Assessment & Interpretation
Assess functional impact and clinical significance of genomic variants
What You Can Do
You can analyze annotated variants from VCF files and prediction tools (VEP, SnpEff, InterVar) to assess pathogenicity, predict functional consequences, and cross-reference multiple annotation sources including ACMG guidelines, CADD scores, and splicing predictions. Claude helps you generate reproducible variant interpretation reports that bridge computational outputs with biological and clinical significance for disease studies, pharmacogenomics, and regulatory submissions.
Features
rank variants by predicted impact (loss-of-function, missense, regulatory) using SIFT, PolyPhen-2, and conservation metrics
cross-reference ACMG pathogenicity criteria, ClinVar, gnomAD population frequencies, and disease-specific databases in a unified framework
assess splicing effects (SpliceAI), protein folding (AlphaFold), and domain disruption for novel variants
connect variants to published evidence linking genotype to phenotype for genes in your panel
generate structured reports with criteria, evidence trails, and confidence assessments for wet lab collaboration and publication
evaluate drug-metabolizer phenotypes and variant-drug interaction significance
build and apply custom criteria for targeted gene panels, cancer hotspots, or monogenic disease genes
Example Output
Example 1: Missense Variant in TP53
- Variant: chr17:7577121 C>T (p.R248Q)
- Predicted Impact: Loss of function (missense in DNA-binding domain)
- ACMG Classification: Likely Pathogenic (PVS1, PS1, PM2_supporting)
- Evidence: Known hotspot in IARC TP53 database; 47 ClinVar submissions as pathogenic; gnomAD frequency <0.0001
- Functional Prediction: PolyPhen-2 = 0.95 (probably damaging); SIFT score = deleterious
- Recommendation: HIGH PRIORITY — strong evidence for functional disruption in cancer context
Example 2: Synonymous Variant in BRCA1 Exon 5
- Variant: chr17:41196312 G>A (p.Asp222=)
- Predicted Impact: Potential splicing disruption
- SpliceAI Score: 0.82 (high confidence for exon skipping)
- Functional Prediction: MaxEntScan indicates 65% reduction in splice site strength
- gnomAD Frequency: 0.0008 (present in population)
- Recommendation: MODERATE PRIORITY — investigate RNA-level consequences; consider functional validation
Example 3: Intergenic Variant Near PTEN Promoter
- Variant: chr10:89654321 A>G
- Predicted Impact: Potential regulatory disruption
- Conservation: phyloP score = 4.2 (moderately conserved across mammals)
- TF Binding Prediction: TRANSFAC indicates altered TP53 binding site
- ClinVar: No submissions; gnomAD frequency = 0.001
- Recommendation: LOW-MODERATE PRIORITY — functional validation recommended before clinical classification
What's Included
- SKILL.md: Core instruction file for variant interpretation workflow and ACMG criteria integration
- Variant Interpretation Template: Structured markdown template for documenting variant assessment with evidence fields
- ACMG Pathogenicity Checklist: Interactive checklist for applying American College of Medical Genetics criteria (PVS, PS, PM, BP, BS categories)
- Annotation Source Reference Guide: Quick-reference table mapping prediction tools (CADD, SpliceAI, PolyPhen-2, SIFT, AlphaFold) to interpretive thresholds
- Literature Integration Workflow: Framework for cross-referencing ClinVar, IARC, dbSNP, and PubMed to support pathogenicity calls
Who It's For
- Bioinformatics scientists — systematize variant interpretation pipelines and standardize reporting across projects
- Computational biologists — prioritize variants for functional validation and reduce time spent on literature manual review
- Clinical geneticists — document evidence trails for rare disease diagnoses and regulatory submissions
- Pharmacogenomics specialists — assess drug-metabolizer phenotypes and predict variant-drug interactions
- Research scientists in oncology — interpret cancer-associated variants and identify driver mutations in tumor panels
Best For
- Variant prioritization from whole-exome or whole-genome sequencing studies
- Pathogenicity assessment for novel variants in monogenic disease genes
- Pharmacogenomics interpretation and drug-metabolizer phenotyping
- Cancer variant annotation and driver mutation identification
- Preparation of variant interpretation reports for publication, patents, or regulatory submissions
You might also like
You can design and execute bioanalytical method validations aligned with FDA Guidance for Industry and ICH guidelines, interpret complex validation data against regulatory acceptance criteria, and systematically troubleshoot analytical failures to identify root causes and corrective actions. This skill accelerates validation timelines by 20–30%, minimizes regulatory rework, and provides structured decision trees for problems that typically require expert consultation.
by kody-wClaude reviews your injection mold, stamping die, or precision tool designs for manufacturability, cost reduction opportunities, and tolerance optimization. You provide CAD specifications, material details, and production volume—Claude identifies specific design modifications, material alternatives, and tolerance adjustments that reduce tooling complexity and unit costs without compromising performance.
by kody-w
You can design end-to-end NGS pipelines tailored to your experiment type (WGS, WES, RNA-seq, targeted), troubleshoot pipeline failures by analyzing QC metrics and logs, and optimize performance by fine-tuning parameters and identifying bottlenecks. This skill handles the full workflow from raw sequencing data quality assessment through variant interpretation and annotation.
This skill evaluates your current workstation setup, identifies ergonomic risks, and delivers actionable recommendations to reduce strain and injury. It analyzes factors like monitor height, desk ergonomics, seating, keyboard positioning, and lighting to create a personalized improvement plan that you can implement immediately.
by kody-w
Systematically evaluate ingredient compatibility against your active pharmaceutical ingredients, predict formulation behavior and stability risks, and troubleshoot phase separation, incompatibility, and irritation issues in real time. Generate ICH-aligned stability protocols, excipient safety summaries, and regulatory-ready documentation that accelerates IND, NDA, and ANDA submissions without replacing lab validation.
by kody-w
Analyze your PLC code and ladder logic to identify logic errors, safety violations, and inefficiencies before they reach production. You'll get detailed diagnostics of control system failures, safety compliance verification against IEC 61131 standards, and optimization recommendations for automation sequences. This skill helps you prevent costly downtime, ensure worker safety, and improve system performance across manufacturing operations.
by kody-w
You can systematically identify production bottlenecks, forecast capacity constraints before they impact delivery, and optimize resource utilization across your manufacturing operations. By analyzing historical production data, demand forecasts, and resource availability, you'll generate actionable insights to maximize throughput and reduce downtime.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w